Source: BioPharma-Reporter

Treefrog Interactive: Umoja and TreeFrog team up to overcome challenges facing ex vivo allogeneic therapies

Umoja Biopharma and TreeFrog Therapeutics have formed an alliance to address challenges facing ex vivo allogeneic therapies in immuno-oncology, including issues scaling up production to reach all patients.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Sean Stephens's photo - CEO of Treefrog Interactive

CEO

Sean Stephens

CEO Approval Rating

66/100

Read more